203Hg-labelled methyl mercury chloride retention in man after inhalation.
作者信息
Uchiyama M, Akiba S, Ohmomo Y, Tanaka G, Watabe T, Ishihara T, Takizawa Y
出版信息
Health Phys. 1976 Oct;31(4):335-42. doi: 10.1097/00004032-197610000-00004.
Abstract
摘要
相似文献
1
203Hg-labelled methyl mercury chloride retention in man after inhalation.吸入后人体对203汞标记的氯化甲基汞的潴留情况
Health Phys. 1976 Oct;31(4):335-42. doi: 10.1097/00004032-197610000-00004.
2
The octanol/water distribution of mercury compounds.
Arch Toxicol. 1985 Jun;57(2):139-41. doi: 10.1007/BF00343125.
3
The retention and distribution of radioactive mercuric oxide following accidental inhalation.意外吸入放射性氧化汞后的潴留与分布
Ann Occup Hyg. 1978 Mar;21(1):21-32. doi: 10.1093/annhyg/21.1.21.
4
The distribution and biological half-time of 203Hg in the human body according to a modified whole-body counting technique.根据改进的全身计数技术测定人体中203汞的分布及生物半衰期。
Environ Physiol Biochem. 1975;5(4):252-7.
5
Retention of neohydrin-Hg203 as determined with a total-body scintillation counter.用全身闪烁计数器测定新氢汞剂-Hg203的潴留情况。
Radiology. 1962 Jun;78:970-3. doi: 10.1148/78.6.970.
6
Standardization and decay data determinations of 125I, 54Mn and 203Hg.125I、54Mn和203Hg的标准化及衰减数据测定
Appl Radiat Isot. 2006 Oct-Nov;64(10-11):1440-5. doi: 10.1016/j.apradiso.2006.02.058. Epub 2006 Apr 18.
7
8
[Principles of kidney scintigraphy with Hg-203 labelled Salyrgan].[用汞-203标记的撒利汞进行肾脏闪烁扫描的原理]
Nucl Med (Stuttg). 1961 Sep 1;2:71-9.
9
The urinary excretion and biologic decay periods of radiomercury labeling a mercurial diuretic in normal and diseased man.正常人和患病者体内放射性汞标记的汞利尿剂的尿排泄及生物衰变期
J Clin Invest. 1950 Sep;29(9):1131-8. doi: 10.1172/JCI102350.
10
The kinetics of intravenously administered methyl mercury in man.静脉注射甲基汞在人体中的动力学。
Toxicol Appl Pharmacol. 1994 Oct;128(2):251-6. doi: 10.1006/taap.1994.1204.
Zotero 插件